The present invention provides a compound which has an inhibitory activity on lysine-specific demethylase 1 and is useful as a medicinal agent such as a prophylactic or therapeutic agent for cancer and central nervous system diseases. The present invention relates to a compound represented by formula (I) [wherein A represents a hydrocarbon or heterocyclic ring group which may have a substituent; R represents H or a hydrocarbon or heterocyclic ring group which may have a substituent; A and R may be bound together to form a ring which may have a substituent; Q
申请公布号
AU2012293223(B2)
申请公布日期
2017.03.02
申请号
AU20120293223
申请日期
2012.08.08
申请人
Takeda Pharmaceutical Company Limited
发明人
Tomita, Naoki;Kajii, Shigeo;Cary, Douglas Robert;Tomita, Daisuke;Imamura, Shinichi;Tsuchida, Ken;Matsuda, Satoru;Hara, Ryujiro